Uncategorised - European Medical Journal

Unmet Needs in ER+/HER2- Advanced Breast Cancer Therapy

This infographic, the first in a three-part series, explores the development of resistance to endocrine therapy in ER-Positive, HER2-Negative advanced…

Skin Microbiome and Acne: Microbial Imbalances and Impact

Join dermatology experts Thomas Dirschka, Alison Layton, and Marco Rocha in this engaging audio recap of the article as they explore the…

Key Player in Melanoma Progression Identified

A new study has revealed how the protein Rab7a enhances the activity of TPC2, a cellular channel linked to melanoma, the deadliest form of skin cancer.

How To Talk To Your Patient About Cannabis

Medical cannabis, a widely debated topic, took center stage at the ACR Convergence 2024, where researchers explored its role in managing chronic pain related to rheumatic diseases.

Orange lungs on yellow background

AstraZeneca supports first asthma and COPD breakthrough in 50 years

Research supported by AstraZeneca has demonstrated that a single dose of benralizumab significantly reduces treatment failure rates – by four times compared to traditional steroid tablets.

Evolving Patient Centered Therapies for Metastatic NSCLC

The metastatic non-small cell lung cancer (mNSCLC) treatment landscape has vastly expanded over the past two decades as a result of…

AI Voice Analysis Detects Early Parkinson’s with 99% Accuracy

AI voice analysis shows 99% accuracy in detecting Parkinson’s disease early, paving the way for better patient care.

Alternative LDL Lowering Strategy as Effective as Statins for Atherosclerosis

Alternative LDL cholesterol-lowering strategy offers similar outcomes to statins, with fewer side effects and better safety.

HIV Then and Now: Advances in Immunity and Vaccination

This week, Jonathan welcomes Mark Connors to explore advancements in HIV vaccine technology and the progress in global understanding of HIV since the 1980s.

Reduced-Dose Steroids Linked to Higher Relapse Risk in ANCA-Associated Vasculitis

Reduced-dose steroids increase relapse and progression risk in ANCA-associated vasculitis, particularly in rituximab-treated patients, study shows.